Skye Bioscience to Present at Upcoming Investment Conferences
Skye Bioscience, Inc. (NASDAQ: SKYE) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $25.00 price target on the stock.
Skye Bioscience, Inc. (OTCMKTS: SKYE) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $25.00 price target on the stock.
Skye Bioscience Uplists to The Nasdaq Global Market
Skye Bioscience, Inc. (OTCMKTS: SKYE) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $20.00 price target on the stock, up previously from $12.00.